Bliss GVS Pharma shareholders and shareholding pattern
NSE: BLISSGVSBSE: 506197Pharmaceuticals & BiotechnologySmall Cap
Last close ₹623.35down ₹19.35 (3.01%)BSE ₹628.50
Share price at the NSE close on 23 Oct 2026. Previous close ₹642.70.
52-week range of traded prices to 23 Oct 2026
₹118.00Low, 10 Nov 2025₹739.90High, 28 Sep 2026
- Under NSE's long-term additional surveillance, stage IV, on the list for 23 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Delivery only: shares bought must be paid for in full, with no selling on the same day.
- Next results date: the board meets on 29 Oct 2026 to consider: financial results and other business matters.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹6,628 Cr1,000th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 12 Aug 2026
- 48.7
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 12 May 2026
- 5.6
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.24%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 12 Aug 2026
- 12.1%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 12 Aug 2026
- 12.3%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 12 May 2026
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day.
- 1,58,050
Who owns Bliss GVS Pharma, filing by filing
Per cent of the company's shares. The last ten years of filings, from Dec 2016; the latest is the filing for Sep 2026.
Sep 2026 filing
- Promoters50.07%
- Foreign institutions5.03%
- Indian institutions9.62%
- Individuals and others35.28%
Shareholding pattern, per cent, from Sep 2022
- Promoters
- Foreign institutions
- Indian institutions
- Individuals and others
| Per cent | Dec 2016Filed 17 Jan | Mar 2017Filed 10 Apr | Jun 2017Filed 12 Jul | Sep 2017Filed 17 Oct | Dec 2017Filed 14 Jan | Mar 2018Filed 12 Apr | Jun 2018Filed 18 Jul | Sep 2018Filed 15 Oct | Dec 2018Filed 31 Jan | Mar 2019Filed 20 Apr | Jun 2019Filed 15 Jul | Sep 2019Filed 22 Oct | Dec 2019Filed 15 Jan | Mar 2020Filed 7 May | Jun 2020Filed 22 Jul | Sep 2020Filed 21 Oct | Dec 2020Filed 16 Jan | Mar 2021Filed 20 Apr | Jun 2021Filed 20 Jul | Sep 2021Filed 20 Oct | Dec 2021Filed 13 Jan | Mar 2022Filed 20 Apr | Jun 2022Filed 20 Jul | Sep 2022Filed 21 Oct | Dec 2022Filed 20 Jan | Mar 2023Filed 18 Apr | Jun 2023Filed 21 Jul | Sep 2023Filed 17 Oct | Dec 2023Filed 19 Jan | Mar 2024Filed 17 Apr | Jun 2024Filed 19 Jul | Sep 2024Filed 21 Oct | Dec 2024Filed 17 Jan | Mar 2025Filed 16 Apr | Jun 2025Filed 21 Jul | Sep 2025Filed 17 Oct | Dec 2025Filed 21 Jan | Mar 2026Filed 17 Apr | Jun 2026Filed 21 Jul | Sep 2026Filed 21 Oct |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 60.16% | 60.16% | 60.16% | 60.16% | 60.16% | 60.16% | 60.16% | 60.16% | 50.47% | 41.60% | 41.53% | 41.53% | 41.60% | 41.60% | 41.60% | 41.60% | 33.31% | 33.31% | 33.24% | 33.19% | 33.14% | 33.14% | 34.51% | 34.55% | 34.46% | 35.04% | 35.12% | 35.06% | 34.97% | 34.97% | 34.90% | 34.82% | 35.10% | 35.29% | 35.44% | 35.39% | 35.36% | 35.36% | 35.01% | 50.07% | |
| Indian promoters | 60.16% | 60.16% | 60.16% | 60.16% | 60.16% | 60.16% | 60.16% | 60.16% | 50.47% | 41.60% | 41.53% | 41.53% | 41.60% | 41.60% | 41.60% | 41.60% | 33.31% | 33.31% | 33.24% | 33.19% | 33.14% | 33.14% | 34.51% | 34.55% | 34.46% | 35.04% | 35.12% | 35.06% | 34.97% | 34.97% | 34.90% | 34.82% | 35.10% | 35.29% | 35.44% | 35.39% | 35.36% | 35.36% | 35.01% | 50.07% |
| Public. Every shareholder outside the promoter group, the employee trusts and the shares held against depositary receipts, as the filing totals them. | 39.84% | 39.84% | 39.84% | 39.84% | 39.84% | 39.84% | 39.84% | 39.84% | 49.53% | 58.40% | 58.47% | 58.47% | 58.40% | 58.40% | 58.40% | 58.40% | 66.69% | 66.69% | 66.76% | 66.81% | 66.86% | 66.86% | 65.49% | 65.45% | 65.54% | 64.96% | 64.88% | 64.94% | 65.03% | 65.03% | 65.10% | 65.18% | 64.90% | 64.71% | 64.56% | 64.61% | 64.64% | 64.64% | 64.99% | 49.93% |
| Promoter shares pledgedShare of the promoters' own shares | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.33% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 95.77% |
| Shares in issue | 10,31,46,672 | 10,31,46,672 | 10,31,46,672 | 10,31,46,672 | 10,31,46,672 | 10,31,46,672 | 10,31,46,672 | 10,31,46,672 | 10,31,46,672 | 10,31,46,672 | 10,31,46,672 | 10,31,46,672 | 10,31,46,672 | 10,31,46,672 | 10,31,46,672 | 10,31,46,672 | 10,31,46,672 | 10,31,46,672 | 10,33,57,172 | 10,35,08,922 | 10,36,77,922 | 10,36,77,922 | 10,38,08,172 | 10,38,84,922 | 10,41,52,672 | 10,41,52,672 | 10,42,23,172 | 10,43,98,672 | 10,46,90,822 | 10,46,90,822 | 10,48,82,572 | 10,51,44,472 | 10,53,66,272 | 10,53,70,272 | 10,54,97,522 | 10,56,49,472 | 10,57,88,972 | 10,57,88,972 | 10,60,56,222 | 10,63,30,472 |
| Shares locked inShares locked in. Shares the filing reports as barred from sale until a set day, such as promoters' shares after a public issue or shares allotted to an investor directly. | – | – | – | – | – | – | – | – | – | – | – | 1,120 | 1,120 | – | – | – | – | – | 2,10,500 | 2,10,500 | 3,20,750 | 1,69,000 | 1,30,250 | 2,07,000 | 3,44,500 | 2,67,750 | 70,500 | 2,46,000 | 1,93,500 | 2,92,150 | 46,750 | 4,53,650 | 4,83,700 | 2,25,800 | 1,27,250 | 2,39,250 | 2,91,450 | 1,39,500 | 2,67,250 | 5,41,500 |
Filings before Sep 2022 are on an older form, which did not split institutions into foreign and Indian and grouped some holders differently, so those columns show only the lines both forms state alike. Pledged is the share of the promoters' own shares given to lenders as security. A dash is a line the filing did not state. “Under 0.01%” is a holding of shares too small to show at two decimals.
Bliss GVS Pharma promoters
Promoters are the founders, families and companies that control the company, as its filings name them. Every member of the promoter group holding shares in the filing for Sep 2026; the largest is MATES VISA CONSULTANCY PRIVATE LIMITED, 47.95%. The filing names 13 more members with no shares.Promoter buying and selling
| Holder | |||
|---|---|---|---|
| MATES VISA CONSULTANCY PRIVATE LIMITEDIndian companies, trusts and others | 47.95% | 5,09,84,595 | 100.00% |
| ANUPAM RASAYAN INDIA LIMITEDIndian companies, trusts and others | 2.12% | 22,51,669 | 0.00% |
Pledged is the share of the holder's own shares pledged to a lender.
Largest public holders of Bliss GVS Pharma, filing by filing
Per cent, on the same shares as the split above.
| Holder | Dec 2016Filed 17 Jan | Mar 2017Filed 10 Apr | Jun 2017Filed 12 Jul | Sep 2017Filed 17 Oct | Dec 2017Filed 14 Jan | Mar 2018Filed 12 Apr | Jun 2018Filed 18 Jul | Sep 2018Filed 15 Oct | Dec 2018Filed 31 Jan | Mar 2019Filed 20 Apr | Jun 2019Filed 15 Jul | Sep 2019Filed 22 Oct | Dec 2019Filed 15 Jan | Mar 2020Filed 7 May | Jun 2020Filed 22 Jul | Sep 2020Filed 21 Oct | Dec 2020Filed 16 Jan | Mar 2021Filed 20 Apr | Jun 2021Filed 20 Jul | Sep 2021Filed 20 Oct | Dec 2021Filed 13 Jan | Mar 2022Filed 20 Apr | Jun 2022Filed 20 Jul | Sep 2022Filed 21 Oct | Dec 2022Filed 20 Jan | Mar 2023Filed 18 Apr | Jun 2023Filed 21 Jul | Sep 2023Filed 17 Oct | Dec 2023Filed 19 Jan | Mar 2024Filed 17 Apr | Jun 2024Filed 19 Jul | Sep 2024Filed 21 Oct | Dec 2024Filed 17 Jan | Mar 2025Filed 16 Apr | Jun 2025Filed 21 Jul | Sep 2025Filed 17 Oct | Dec 2025Filed 21 Jan | Mar 2026Filed 17 Apr | Jun 2026Filed 21 Jul | Sep 2026Filed 21 Oct |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CLARUS CAPITAL IAlternative investment funds | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 3.51% | 4.99% |
| INVESTOR EDUCATION AND PROTECTION FUND AUTHORITY MINISTRY OF CORPORATE AFFAIRSInvestor education fund | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 2.20% | 2.20% | 2.27% | 2.26% | 2.30% | 2.30% | 2.36% | 2.36% | 2.35% | 2.34% | 2.39% | 2.39% | 2.38% | 2.38% | 2.37% | 2.45% | 2.44% | 2.42% | 2.51% | 2.50% | 2.48% | 2.46% |
| 360 ONE PIPE FUNDAlternative investment funds | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.16% | 1.99% |
| COEUS GLOBAL OPPORTUNITIES FUNDForeign portfolio investors, category I | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.77% | 1.76% | 1.76% | 1.76% | 1.76% | 1.76% | 1.76% | 1.75% | 1.75% |
| LIFE INSURANCE CORPORATION OF INDIAInsurance companies | – | – | – | – | – | – | – | – | – | – | 2.91% | 2.91% | 2.91% | 2.91% | 2.91% | 5.72% | 5.72% | 6.69% | 6.68% | 6.67% | 6.66% | 6.66% | 6.65% | 6.64% | 6.63% | 6.63% | 6.62% | 6.61% | 6.59% | 6.59% | 6.58% | 6.56% | 6.55% | 6.55% | 6.54% | 5.98% | 5.78% | 4.33% | 3.24% | 1.53% |
| GEE BEE SECURITIES PRIVATE LIMITEDCompanies | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.18% |
| AMIT ASHOK THAWANIResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.06% |
| GULBARGA TRADING AND INVESTMENT PRIVATECompanies | 5.70% | 5.70% | 5.70% | 5.70% | 5.70% | 5.70% | 5.70% | 5.70% | 5.70% | 5.70% | 5.70% | 5.70% | 5.70% | 5.70% | 5.70% | 5.70% | 5.70% | 5.70% | 5.67% | 5.67% | 5.66% | 5.66% | 5.65% | 5.65% | 5.63% | 5.60% | 5.60% | 5.59% | 5.58% | 5.58% | 5.57% | 5.55% | 5.53% | 5.53% | 5.53% | 5.52% | 5.51% | 5.51% | 5.50% | – |
| ARJUN GAUTAM ASHRA .Resident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 4.89% | 4.90% | 4.89% | 4.88% | 4.87% | 4.87% | 4.86% | 4.86% | 4.85% | 4.85% | 4.84% | 4.84% | 4.82% | 4.82% | 4.81% | 4.80% | 4.79% | 4.79% | 4.79% | 4.78% | 4.77% | 4.77% | 4.76% | – |
| GAUTAM RASIKLAL ASHRAResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 2.83% | 2.83% | 2.82% | 2.82% | 2.81% | 2.81% | 2.81% | 2.81% | 2.80% | 2.83% | 2.83% | 2.82% | 2.81% | 2.81% | 2.83% | 2.81% | 2.83% | 2.83% | 2.83% | 2.82% | 2.82% | 2.82% | 2.81% | – |
| ARIAN INVESTMENT LIMITEDForeign portfolio investors, category II | – | – | – | – | – | – | – | – | 9.22% | 9.72% | 9.72% | 9.72% | 9.72% | 9.72% | 9.72% | 9.72% | 9.72% | 9.72% | 9.70% | 9.68% | 9.67% | 9.51% | 9.50% | 9.49% | 9.46% | 9.46% | 9.46% | 9.44% | 9.42% | 9.42% | 8.96% | 8.79% | 8.76% | 8.58% | 7.93% | 7.43% | 4.72% | 2.45% | 1.36% | – |
| MATEUS LTDForeign portfolio investors, category II | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 2.42% | – | 1.08% | – |
| ARK GLOBAL EMERGING COMPANIES, LPForeign portfolio investors, category II | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.71% | 2.50% | 1.42% | – | – |
| QUADRATURE TRADING VCC - SUB-FUND NO. 1Foreign portfolio investors, category I | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.23% | – | – |
| SHAILESH DALMIAResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.18% | – | – |
| Polus Global FundForeign portfolio investors, category I | – | – | – | – | – | – | – | – | – | 4.90% | 5.31% | 5.31% | 5.31% | 5.31% | 5.31% | 5.31% | 5.31% | 5.31% | 4.62% | 4.61% | 3.37% | 1.79% | 1.79% | 1.79% | 1.79% | 1.79% | 1.78% | 1.78% | 1.78% | 1.78% | 1.77% | – | – | – | – | – | – | – | – | – |
| Aspire Emerging FundForeign portfolio investors, category II | – | – | – | – | 1.19% | 3.04% | 3.04% | 3.04% | 3.05% | 3.05% | 3.05% | 3.05% | 3.05% | 3.05% | 3.05% | 3.05% | 3.05% | 2.46% | 2.46% | 2.45% | 2.35% | 2.35% | 2.35% | 2.35% | 2.34% | 2.34% | 2.34% | 2.34% | 2.33% | 2.33% | 1.34% | – | – | – | – | – | – | – | – | – |
| Bhupesh Kumar LodhaResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.26% | – | – | – | – | – | – | – | – | – | – | – |
| Fidelity Puritan Trust-Fidelity Low-Priced Stock FundForeign portfolio investors, category I | 4.46% | 4.46% | 4.46% | 4.46% | 4.46% | 4.46% | 4.46% | 4.46% | 3.64% | 3.59% | 3.59% | 3.59% | 3.59% | 3.59% | 3.59% | 3.59% | 3.59% | 2.91% | 2.90% | 2.90% | 2.89% | 2.43% | 2.31% | 1.93% | 1.92% | 1.91% | 1.91% | 1.82% | – | – | – | – | – | – | – | – | – | – | – | – |
| Jainam Broking LimitedCompanies | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.23% | – | – | – | – | – | – | – | – | – | – | – | – |
| Dishant Milanbhai ParikhResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.15% | 1.15% | 1.14% | 1.15% | 1.15% | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Prarambh Securities Pvt LtdOther non-institutions | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.35% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| L7 Hitech Private LimitedOther non-institutions | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.43% | 1.40% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| GLOBE CAPITAL MARKET LTDOther non-institutions | 1.01% | 1.15% | – | – | – | – | 1.01% | 1.13% | 1.09% | 1.46% | 2.21% | 2.95% | 3.98% | 3.81% | 2.51% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| RAVI OMPRAKASH AGRAWALResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.16% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| AXIS BANK LIMITEDOther non-institutions | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.25% | 1.02% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| GLOBE COMMODITIES LTDOther non-institutions | – | – | – | – | – | – | – | – | – | – | – | 1.54% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| GUINESS SECURITIES LIMITEDOther non-institutions | – | – | – | – | – | 1.37% | 1.37% | 1.01% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| JASHVANT MANSUKHLAL SHAHOther non-institutions | 1.43% | 1.43% | 1.43% | 1.43% | 1.30% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Nirav Commercials LtdOther non-institutions | 1.01% | 1.01% | 1.01% | 1.01% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
A filing names every holder above one per cent, in the company's own words: an insurer's holding can carry one of its funds' names. A dash is a filing that did not name the holder, which includes holding under one per cent.